SHOTGUN PROTEOMIC PROFILING OF HepG2 CELL LINE AS A METHOD APPLICABLE FOR BIOPSY SPECIMEN ANALYSIS
Abstract
About the Authors
S. B. StanisheuskiBelarus
M. Sc. (Chemistry), Junior researcher
A. V. Ivanchyk
Belarus
Ph. D. student, Junior researcher
M. A. Shapira
Belarus
M. Sc. (Biology), Junior researcher
A. V. Yantsevich
Belarus
Ph. D. (Chemistry), Head of Laboratory
A. G. Sysa
Belarus
Ph. D. (Chemistry), Senior researcher
References
1. Bohnenberger H., Ströbel P., Mohr S., Corso J., Berg T., Urlaub H., Lenz C., Serve H., Oellerich T., “Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors”, Journal of Visualized Experiments, 2015, vol. 96, p. 52435.
2. Feist Р., Hummon А. В., “Proteomic Challenges: Sample Preparation Techniques for Microgram-Quantity Protein Analysis from Biological Samples”, International Journal of Molecular Sciences, 2015, vol. 16(2), pp. 3537–3563.
3. Ivanchyk A. V., Shapira M. A., Shchur V. V., Iantsevich A. V., “Optimization of separate stages of sample preparation in proteomic analysis”, Sovremennye problemy biokhimii : sbornik nauchnykh statei I Belorusskogo biokhimicheskogo kongressa, Grodno, 5–6 iiulia 2016 g. : v 2 chastiakh, Nadol’nik L. I. (gl. red.), Grodno, 2016 [Modern problems of biochemistry: a collection of scientific articles of the I Belorussian Biochemical Congress, Grodno, July 5–6, 2016: in 2 parts, Nadolnik L. I. (ed.), Grodno, 2016], IurSaPrint, Grodno, BY, 2016, part 2, pp. 169–174.
4. “HepG2 (liver hepatocellular carcinoma): cell culture and transfection protocol”, Available at: http://www.hepg2.com, (accessed 10.11.16).
5. Lebret T., Watson R. W., Molinié V., O’Neill A., Gabriel C., Fitzpatrick J. M., Botto H., “Heat shock proteins HSP27, HSP60, HSP70, and HSP90 expression in bladder carcinoma”, Cancer, 2003, vol. 98(5), pp. 970–977.
6. Wang R. C., Huang C. Y., Pan T. L., Chen W. Y., Ho C. T., Liu T. Z., Chang Y. J., “Proteomic Characterization of Annexin l (ANX1) and Heat Shock Protein 27 (HSP27) as Biomarkers for Invasive Hepatocellular Carcinoma Cells”, PLoS One, 2015, vol. 10, pp. 2–10.
7. Nirde P., Derocq D., Maynadier M., Chambon M., Basile I., Gary-Bobo M., Garcia1 M., “Heat shock cognate 70 protein secretion as a new growth arrest signal for cancer cells”, Oncogene, 2010, vol. 29, pp. 117–127.
8. Huttunen K. M., Raunio H., Rautio J., “Prodrugs from serendipity to rational design”, Pharmacological Reviews, 2011, vol. 63 (3), pp. 750–761.
9. Pinto N., “Drug focus: Pharmacogenetic studies related to cyclophosphamide-based therapy”, Pharmacogenomics, 2009, vol. 10, pp. 1897–1903.
10. Yang X., Cao W., Zhou J., Zhang W., Zhang X., Lin W., Fei Z., Lin H., Wang B., “14-3-3 zeta positive expression is associated with a poor prognosis in patients with glioblastoma”, Neurosurgery, 2011, vol. 68 (4), pp. 932–938.